Top Pharmaceutical Companies by Revenue 2024

About This Dataset

The world's largest pharmaceutical and biopharmaceutical companies ranked by total revenue in 2024, measured in billions of USD. Johnson & Johnson, AbbVie, and Pfizer compete for the top position, with the landscape shifting significantly due to patent cliffs and the emergence of GLP-1 weight loss drugs as a new blockbuster category.

Analysis

Johnson & Johnson (88.8), Pfizer (63.6) and Merck & Co. (63.6) take the top three in Revenue (Billion USD) in 2024. No single entity dominates: the leader, Johnson & Johnson, holds 18.2% of the combined total of all 8. Below the top two the field is tightly packed: the remaining 6 run from 63.6 down to 47.7 Revenue (Billion USD).

Source: Wikipedia

Key Findings

🏆

Johnson & Johnson leads in Revenue (Billion USD) with 88.80 in 2024.

📊

Average Revenue (Billion USD) in 2024: 61 · median: 58.

↔️

Gap in 2024: Johnson & Johnson is 1.9× larger than Novartis.

Top Pharmaceutical Companies by Revenue 2024

Bar

H-Bar

Line

Area

🗺 Map

Table

Data Insights Below

Data Insights

Numbers, trends & sources behind this chart

Admin

⬡

Data Points

8 categories · 1 year

↑

Top Value

88.80

Johnson & Johnson

Revenue (Billion USD) · 2024

◈

Metrics

Revenue (Billion USD)

◷

Period

2024

Single year snapshot

Methodology & source

Data source: Wikipedia
Coverage: 8 entities · 2024 · 8 observations
Measure: Revenue (Billion USD)
Last updated: 6 September 2026
Compiled by: The ANYSTAT team, from the source above

How the figures are calculated

Values are shown as reported by the source. Nothing is rescaled, rebased or converted — the only changes are thousand separators and decimals shown to two places.
Entities are ranked highest-first on their value in 2024.